Research and experimental development on natural sciences and engineering
MIM PHARMA AS
Revenue 2024
NOK 22
Operating profit
NOK −35,000
Equity
NOK −261,000
Incorporated
2013
Share capital
NOK 60,000
Varemerker (3)
| Name | Application no. | Reg. no. | Status | Status date | Expires |
|---|---|---|---|---|---|
| SaliraVira | 202100570 | 313569 | Registrert | 2021-01-21 | 2031-01-14 |
| sinavita | 202003950 | 309138 | Registrert | 2020-03-30 | 2030-03-20 |
| Godtegrisen | 201804589 | 297571 | Registrert | 2018-04-17 | 2028-04-05 |
Source: Patentstyret
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.